- Home
- NAGE vs REA Comparison
NAGE vs REA Comparison
Compare NAGE & REA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | REA |
|---|---|---|
| Founded | 1999 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 205.9M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | NAGE | REA |
|---|---|---|
| Price | $2.43 | $7.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $12.08 | ★ $25.53 |
| AVG Volume (30 Days) | ★ 521.4K | 125.5K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.82 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $129,423,000.00 | N/A |
| Revenue This Year | $2.85 | N/A |
| Revenue Next Year | $16.67 | N/A |
| P/E Ratio | $27.83 | ★ N/A |
| Revenue Growth | ★ 29.95 | N/A |
| 52 Week Low | $2.43 | $6.20 |
| 52 Week High | $7.95 | $17.84 |
Technical Indicators
Market Signals| Indicator | NAGE | REA |
|---|---|---|
| Relative Strength Index (RSI) | 29.44 | 28.49 |
| Support Level | N/A | $6.20 |
| Resistance Level | $3.61 | $10.58 |
| Average True Range (ATR) | 0.08 | 0.66 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 2.99 | 19.43 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About REA Rare Earths Americas Inc. Common Stock
Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goias, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.